No photo of Gerald Watts

View Scopus Profile

Gerald Watts

Winthrop Professor, DSc MB BS Lond., PhD W.Aust., DM S'ton, FRCP, FRACP

  • The University of Western Australia (M570), 35 Stirling Highway,

    6009 Perth

    Australia

  • 21269 Citations
  • 71 h-Index
1994 …2020
If you made any changes in Pure these will be visible here soon.

Research Output 1994 2019

Filter
Literature review
2017
3 Citations (Scopus)

Insulin resistance and vascular dysfunction in chronic kidney disease: Mechanisms and therapeutic interventions

Chan, D. T., Watts, G. F., Irish, A. B. & Dogra, G. K., Aug 2017, In : Nephrology, Dialysis, Transplantation. 32, 8, p. 1274–1281 8 p.

Research output: Contribution to journal › Literature review

Open Access
Chronic Renal Insufficiency
Blood Vessels
Insulin Resistance
Cardiovascular Diseases
Insulin
2015
5 Citations (Scopus)

Contemporary and Novel Therapeutic Options for Hypertriglyceridemia

Bell, D. A. & Watts, G. F., 1 Dec 2015, In : Clinical Therapeutics. 37, 12, p. 2732-2750 19 p.

Research output: Contribution to journal › Literature review

Hypertriglyceridemia
Triglycerides
Therapeutics
PubMed
Action Potentials
2014
10 Citations (Scopus)

Managing recalcitrant hypercholesterolemia in patients on current best standard of care: Efficacy and safety of novel pharmacotherapies

Sahebkar, A. & Watts, G., 2014, In : Clinical Lipidology. 9, 2, p. 221-233

Research output: Contribution to journal › Literature review

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Standard of Care
Hypercholesterolemia
Hyperlipoproteinemia Type II
Apolipoproteins B
136 Downloads (Pure)

Origin and therapy for hypertriglyceridaemia in type 2 diabetes

Pang, J., Chan, D. C. & Watts, G. F., 15 Apr 2014, In : WORLD JOURNAL OF DIABETES. 5, 2, p. 165-175 11 p.

Research output: Contribution to journal › Literature review

Open Access
File
Hypertriglyceridemia
Type 2 Diabetes Mellitus
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Cardiovascular Diseases
Therapeutics
2011
62 Citations (Scopus)

Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient

Watts, G. & Karpe, F., Mar 2011, In : Heart. 97, 5, p. 350-356 7 p.

Research output: Contribution to journal › Literature review

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Dyslipidemias
Omega-3 Fatty Acids
Triglycerides
Fenofibrate
2005
56 Citations (Scopus)

Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy

Woodman, R. J., Chew, G. & Watts, G., 2005, In : Drugs. 65, 1, p. 31-74 44 p.

Research output: Contribution to journal › Literature review

Type 2 Diabetes Mellitus
Blood Vessels
Lipids
Oxidative Stress
Dyslipidemias
2004

Dyslipidemia in the metabolic syndrome

Chan, D. & Watts, G., 2004, In : Journal of Drug Evaluation. 1, p. 3-34

Research output: Contribution to journal › Literature review

1999
19 Citations (Scopus)

Endothelial dysfunction, insulin resistance and diabetes: exploring the web of causality

Playford, D. & Watts, G., 1999, In : Australian and New Zealand Journal of Medicine. 29, 4, p. 523-534

Research output: Contribution to journal › Literature review

129 Citations (Scopus)

Fibrates, dyslipoproteinaemia and cardiovascular disease

Watts, G. & Dimmitt, S. B., 1999, In : Current Opinion in Lipidology. 10, 6, p. 561-574

Research output: Contribution to journal › Literature review

1997
7 Citations (Scopus)

Endothelial Dysfunction, Insulin Resistance and Non-insulin-dependent Diabetes

Chowienczyk, P. J. & Watts, G., 1997, In : Endocrinology and Metabolism. 4, n/a, p. 225-232

Research output: Contribution to journal › Literature review

5 Citations (Scopus)

Paradise regained: insights into coronary heart disease prevention from recent clinical trials and basic research

Lewis, B. & Watts, G., 1997, In : Journal of the Royal College of Physicians of London. 31, 3; May/June, 1997, p. 263-275

Research output: Contribution to journal › Literature review

1996
46 Citations (Scopus)

Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: new evidence, implications and outstanding issues

Watts, G. & Burke, V., Dec 1996, In : Current Opinion in Lipidology. 7, 6, p. 341-355

Research output: Contribution to journal › Literature review

Primary Prevention
Secondary Prevention
Coronary Disease
Coronary Artery Disease
Pravastatin
157 Citations (Scopus)

Role of cholesterol in regulating apolipoprotein B secretion by the liver

Thompson, G. R., Naoumova, R. P. & Watts, G., Mar 1996, In : Journal of Lipid Research. 37, p. 439-447

Research output: Contribution to journal › Literature review

Cholesterol Esters
Apolipoproteins B
Liver
Cholesterol Ester Storage Disease
Cholesterol
12 Citations (Scopus)

Stable Isotopes in Lipoprotein Research: Kinetic Studies of Very Low Density Lipoprotein Apolipoprotein B-100 Metabolism in Human Subjects

Cummings, M. H. & Watts, G., 1996, In : Watts & Cummings Stable Isotapes. 3, N/A, p. 73-89

Research output: Contribution to journal › Literature review

1994
1 Citation (Scopus)

Lipid-lowering drugs in the management of atherosclerosis

Johnston, J. D. & Watts, G., 1994, In : Current Practice in Surgery. p. 45-51

Research output: Contribution to journal › Literature review

Lipid-lowering therapy and regression of atherosclerosis

Watts, G., 1994, In : Endocrinology and Metabolism. 1, 2, p. 71-87

Research output: Contribution to journal › Literature review